RemSleep Holdings (RMSL) EBIT Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 18.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.80% |
| Sep 30, 2025 | -95.30% |
| Jun 30, 2025 | 27.28% |
| Mar 31, 2025 | 5.29% |
| Dec 31, 2024 | -15.93% |
| Sep 30, 2024 | -33.35% |
| Jun 30, 2024 | -30.01% |
| Mar 31, 2024 | -9.63% |
| Dec 31, 2023 | -69.34% |
| Sep 30, 2023 | -67.14% |
| Jun 30, 2023 | -24.59% |
| Mar 31, 2023 | -40.67% |
| Dec 31, 2022 | -65.88% |
| Sep 30, 2022 | -39.69% |
| Jun 30, 2022 | 45.16% |
| Mar 31, 2022 | -45.80% |
| Dec 31, 2021 | -31.73% |
| Sep 30, 2021 | 30.41% |
| Jun 30, 2021 | 23.94% |
| Mar 31, 2021 | 13.29% |
| Dec 31, 2020 | -36.81% |
| Sep 30, 2020 | 19.02% |
| Jun 30, 2020 | 26.16% |
| Mar 31, 2020 | 22.81% |
| Dec 31, 2019 | 18.58% |
| Sep 30, 2019 | -675.59% |
| Jun 30, 2019 | -764.84% |
| Mar 31, 2019 | -23.84% |
| Dec 31, 2018 | 217.27% |
| Sep 30, 2018 | -918.41% |
| Jun 30, 2018 | -99.59% |
| Mar 31, 2018 | -61.76% |
| Dec 31, 2017 | -0.90% |
| Dec 31, 2016 | -11.78% |
| Sep 30, 2016 | 89.40% |
| Jun 30, 2016 | 84.13% |
| Mar 31, 2016 | 49.70% |
| Dec 31, 2015 | 62.90% |
| Sep 30, 2015 | 92.12% |
| Jun 30, 2015 | 61.06% |
| Mar 31, 2015 | -25.57% |
| Dec 31, 2014 | -54.04% |
| Dec 31, 2013 | 89.80% |
| Sep 30, 2013 | 15.22% |